Heat Biologics to Present at 29th Annual ROTH Conference

Mar 9, 2017

Heat Biologics Announces Agreement to Acquire Pelican Therapeutics

Mar 8, 2017

Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting

Mar 2, 2017

Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium

Feb 17, 2017

Heat Biologics to Present at the Genitourinary Cancers Symposium

Feb 14, 2017

Heat Biologics to Present at NobleCon13

Jan 24, 2017

Heat Biologics to Present at Biotech Showcase 2017 Conference in San Francisco

Jan 5, 2017

Heat Biologics Appoints Jeff Hutchins, Ph.D., as Chief Scientific Officer

Jan 4, 2017

Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results

Dec 6, 2016

Heat Biologics Presents Topline HS-410 Phase 2 Bladder Cancer Results at the Society of Urological Oncology Annual Meeting

Nov 30, 2016